Clover Biopharmaceuticals (HKSE:02197) Purchase Of Investment : HK$-7.73 Mil (TTM As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Clover Biopharmaceuticals Purchase Of Investment?

Clover Biopharmaceuticals's purchase of investment for the six months ended in Jun. 2024 was HK$-8.17 Mil. It means Clover Biopharmaceuticals spent HK$8.17 Mil on purchasing investments. Clover Biopharmaceuticals's purchase of investment for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-7.73 Mil.

Compared with last quarter (HK$0.45 Mil in Dec. 2023 ), Clover Biopharmaceuticals spent more money on purchasing investments in Jun. 2024 (HK$-8.17 Mil).

Clover Biopharmaceuticals Purchase Of Investment Historical Data

The historical data trend for Clover Biopharmaceuticals's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clover Biopharmaceuticals Purchase Of Investment Chart

Clover Biopharmaceuticals Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Purchase Of Investment

-332.31

-36.73

-15.56

Clover Biopharmaceuticals Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Purchase Of Investment	Get a 7-Day Free Trial				-	-	-0.45	0.45	-8.17

Clover Biopharmaceuticals Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-7.73 Mil.

Clover Biopharmaceuticals Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Clover Biopharmaceuticals's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Clover Biopharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clover Biopharmaceuticals Ltd (HKSE:02197) » Definitions » Purchase Of Investment

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 758 West Nanjing Road, Room 1901, Jing’an District, Shanghai, CHN

Website

https://www.cloverbiopharma.com

Clover Biopharmaceuticals Ltd is a clinical-stage biotechnology company committed to developing novel vaccines and biologic therapeutic candidates for infectious diseases as well as cancer and autoimmune diseases.

Executives

Liang Peng	2101 Beneficial owner
Liang Joshua G	2501 Other
Jpmorgan Chase & Co.	2201 Interest of corporation controlled by you
Hillhouse Investment Management, Ltd.	2102 Investment manager
Aut-xxi Investment Holdings Limited	2201 Interest of corporation controlled by you
Jnry V Holdings Limited	2101 Beneficial owner
Aut-xxi Hk Holdings Limited	2101 Beneficial owner
Aut-xxi Holdings Limited	2201 Interest of corporation controlled by you
Hh Imv Holdings, L.p.	2201 Interest of corporation controlled by you
Hillhouse Fund Iv, L.p.	2201 Interest of corporation controlled by you
Temasek Holdings (private) Limited	2201 Interest of corporation controlled by you
The Core Trust Company Limited	2301 Trustee
Tct (bvi) Limited	2501 Other
Super Novel International Limited	2306 Nominee for another person
Shang Hai Tian He Sheng Tai Qi Ye Guan Li He Huo Qi Ye You Xian He Huo

Clover Biopharmaceuticals Headlines

No Headlines